Lecture 11: TGFb Flashcards
Cancer paradox of TGFB
Generally works in opposition to cell proliferation and tumor suppressor
but can also enhance motility and migration, participates in epithelial to mesenchymal transition which favour metastasis
2 family groups of TGFb
- TGF-B like group (TGFBs, activins, nodals and growth and differentiation factors GDFs)
- Bone Morphogenetic Proteins (BMP) like group (BMPs, most GDFS and anti-mullerian hormone AMH)
TGFB ligand structure
mature ligands determined by a structure called cysteine knot
result from formation of three intramolecular disulfide bonds between 6 highly conserved cysteine
the 7th cysteine mediates dimerization to form biologically active molecule
TGFB receptors
single transmembrane domain
extracellular portion for ligand recognition and binding
TGFB type 1 receptor
7 type 1 receptors
unique are called TGFBR1
TGFB type II receptor
5 type II receptors
unique and called TGFBR2
TGFB type III receptors
B-glycan and TGFBR3
acts as scaffold
Chordin
decoy receptor in the extracellular space to inactivate TGFB
3 steps in TGFB signalling
- TGFB associates with B-glycan coreceptor (TGFBR3)
- Complex recognize by TGFBR2 and undergoes dimerization and autophosphorylation
- TGFBR2 recruit 2 molecules of TGFBR1 and phosphorylates it
SMADs
TGFBR1 recruit and phosphorylate SMAD2 or 3 with the help from SARA
SMAD6 or 7 can inhibit the phosphorylation
phosphorylated SMAD2/3 associate with SMAD4 and translocate into nucleus
recruits coactivators and corepressors to trigger transcription
SMURF and SKI
SMAD ubiquitinylation regulating factor targets SMAD2/3 to proteasome
SKI inhibits transcription in nucleus
TGFB as tumor suppressor gene
loss of TGFBR3 gene expression - breast and lung cancer
mutations of TGFBR2 and SMAD4 - colon, pancreas and lung cancer
TGFB on metastasis formation
- inhibition of kinase activity of TGFBR1 inhibits formation of lung metastasis
- potent induce of EMT through SMAD action on SNAI1 (SNAIL), SNAI2 (SLUG) and TWIST
- angiogenesis
3 Pharmacological targets in TGFB
- ligand level - prevent TGFB synthesis
- ligand-receptor level - prevent ligand - receptor interaction
- intracellular level - TGFB receptor kinase inhibitor prevents signal transduction
Targeting SMAD proteins
hard to target
Peptide aptamers can inhibit active domains of Smad2 and 3 to disrupt their interactions with Smad4
appear to be functional in vitro
reduce level of Smad2/3 in complex with Smad4 after TGFB stimulation